Verified Nov 2026
Batteries & E-Mobility
·

Franklin Township, New Jersey
·
Since 2007
Catalent Pharma Solutions is a contract development and manufacturing organization (CDMO) founded in 2007 and headquartered in Franklin Township, New Jersey. The company employs 10,000–50,000 people and generates $1–5 billion in revenue. Catalent serves pharmaceutical, biotech, medical device, and industrial equipment sectors across more than 50 facilities on four continents. It provides formulation development, biologics manufacturing, drug delivery technologies, and clinical supply services for over 1,000 customers globally.
Catalent Pharma Solutions at a glance
Revenue
$1-5B
Est. band
Employees
10,000-50,000
Founded
2007
Headquarters
Franklin Township, New Jersey
Certifications
ISO 13485
Import activity
1369
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
1369
Named foreign suppliers
50
Top origins
Argentina · Colombia · United Kingdom · Sri Lanka

Shared foreign counterparties do not establish that these companies buy from Catalent Pharma Solutions.
What this tells a buyer
Catalent manages significant import flows across 20 countries, sourcing materials from suppliers including Gelita do Brasil (3,314 shipments), Divis Laboratories in India (2,348 shipments), and Bespak Europe in the United Kingdom (1,352 shipments).
The company holds ISO 13485 certification and offers capabilities in extrusion, assembly, formulation development, analytical testing, and manufacturing of various dosage forms including oral and specialty delivery systems.
Catalent serves more than 1,000 customers and supports over 7,000 products worldwide, with recent commercial supply agreements announced for oral gel portfolios and expanded tablet supply partnerships.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
19 years in operation (founded 2007).
1,369 US import shipments on record.
Holds ISO 13485 certification(s) per public sources.
Overview
Catalent Pharma Solutions is a contract development and manufacturing organization (CDMO) founded in 2007 and headquartered in Franklin Township, New Jersey. The company employs 10,000–50,000 people and generates $1–5 billion in revenue. Catalent serves pharmaceutical, biotech, medical device, and industrial equipment sectors across more than 50 facilities on four continents. It provides formulation development, biologics manufacturing, drug delivery technologies, and clinical supply services for over 1,000 customers globally.
At a glance
Attribute | Detail |
|---|---|
Founded | 2007 |
Headquarters | Franklin Township, New Jersey |
Employees | 10,000-50,000 |
Revenue | $1-5B (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 |
What Catalent Pharma Solutions makes
The company holds ISO 13485 certification and offers capabilities in extrusion, assembly, formulation development, analytical testing, and manufacturing of various dosage forms including oral and specialty delivery systems.
Products and capabilities described on the company's own site include Extrusion, Assembly (source: catalent.com).
Certifications
Catalent Pharma Solutions is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — dqsglobal.com
Trade and customs footprint
Catalent manages significant import flows across 20 countries, sourcing materials from suppliers including Gelita do Brasil (3,314 shipments), Divis Laboratories in India (2,348 shipments), and Bespak Europe in the United Kingdom (1,352 shipments). US customs bill-of-lading records list 1369 inbound shipments across 50 foreign suppliers, with top origins including Argentina · Colombia · United Kingdom · Sri Lanka.
Latest developments
2026-10-12 — Catalent and Mantra™ Announce Commercial Supply Agreement for Single-Serve Oral Gel Portfolio | Catalent (catalent.com)
2026-09-30 — ALK expands strategic tablet supply partnership with Catalent | ALK (alk.net)
2026-09-10 — Catalent invests in biologics, oral drug manufacturing following refinancing | Pharma Manufacturing (pharmamanufacturing.com)
2026-09-01 — Goodwin Advises Catalent on $4.7 Billion Debt Refinancing | News & Events | Goodwin (goodwinlaw.com)
2026-08-03 — Codis Completes Acquisition of Catalent’s Nottingham, UK Facility,Expanding Europe’s Premier Spray Dry Network - Codis (codis.com)
2026-02-18 — Catalent and S.Biomedics Announce Partnership to Develop and Manufacture TED‑A9 | Catalent (catalent.com)
Company details
Catalent serves more than 1,000 customers and supports over 7,000 products worldwide, with recent commercial supply agreements announced for oral gel portfolios and expanded tablet supply partnerships. Catalent Pharma Solutions was founded in 2007, has an estimated 10,000-50,000 employees, and is headquartered in Franklin Township, New Jersey. On the LightSource stability read it is rated "Established & active": 19 years in operation (founded 2007). 1,369 US import shipments on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Catalent Pharma Solutions make?
Catalent Pharma Solutions is a contract development and manufacturing organization (CDMO) founded in 2007 and headquartered in Franklin Township, New Jersey. The company employs 10,000–50,000 people and generates $1–5 billion in revenue. Catalent serves pharmaceutical, biotech, medical device, and industrial equipment sectors across more than 50 facilities on four continents. It provides formulation development, biologics manufacturing, drug delivery technologies, and clinical supply services for over 1,000 customers globally.
Where is Catalent Pharma Solutions headquartered?
Catalent Pharma Solutions is headquartered in Franklin Township, New Jersey (14 Schoolhouse Road, Franklin Township, New Jersey, 08873).
When was Catalent Pharma Solutions founded?
Catalent Pharma Solutions was founded in 2007.
How big is Catalent Pharma Solutions?
Catalent Pharma Solutions has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).
What certifications does Catalent Pharma Solutions hold?
Catalent Pharma Solutions lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Does Catalent Pharma Solutions import from overseas suppliers?
US customs bill-of-lading records show 1369 inbound shipments for Catalent Pharma Solutions, with top origins including Argentina · Colombia · United Kingdom · Sri Lanka.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
